MAG Foundation providing free archived CME webinar
A recording of the “ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care” webinar that was hosted by the MAG Foundation on October 26, is available as a free archived webinar until March 1, 2014.
Learners can start and stop the webinar at their leisure.
The webinar features P. Tennent Slack, M.D., the Statewide Program Committee chair for the ‘Think About It’ campaign and Susan Blank, M.D., the president-elect of the Georgia Society of Addiction Medicine.
Physicians who successfully complete the webinar and post-webinar evaluation will receive 3 AMA PRA Category 1 Credits. and a certificate of completion that will fulfill any FDA-approved REMS training requirements should the training become mandatory.
The webinar also provides valuable information for non-physicians who are involved in opioid treatments as well. Non-physicians who successfully complete the webinar and post-webinar evaluation will also receive a certificate of completion.
Contact Fred Jones at 678.303.9284 or fjones@mag.org for more information.
This activity has been planned and implemented in accordance with the Essential Areas policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Physicians’ Institute for Excellence in Medicine and the Medical Association of Georgia (MAG). The Physicians’ Institute for Excellence in Medicine is accredited by MAG to provide continuing medical education for physicians.
The Physicians’ Institute designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presented by the MAG Foundation, a cooperating member of the Collaborative on REMS Education (CO*RE) interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see http://www.er-la-opioidREMS.com for a listing of the member companies.
This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).
Contact MAG Foundation Director Fred Jones at fjones@mag.org or 678.303.9284 for more information.
Providing Resources and Education
MAGF is committed to developing and providing continuing medical education (CME) for physicians on their important role in combating prescription drug abuse. We will also be working collaboratively with pharmacists and other allied health professionals to help develop and provide continuing education on their important roles in stopping prescription drug abuse.
The statewide “Think About It” Program Committee, led by Dr. P. Tennent Slack of Gainesville, GA., is developing our CME courses. Offerings will include a course on how physicians can help reduce the misuse and abuse of and addiction to prescription drugs with emphasis on the new rules recently adopted by the Georgia State Board of Medical Examiners, a symposium on pain and pain management, a physician toolkit which physicians can use in their daily practice to help educate their patients on this statewide epidemic and, once up and running, a course on how to incorporate the Prescription Drug Monitoring Program (PDMP) into physicians’ daily practice.
The “Think About It” Campaign also plans to develop informational programs for the public on how to work with their physician to stop the rising tide of prescription drug abuse.
Raising Awareness
The Medical Association of Georgia is uniquely positioned to reach and engage Georgia’s physicians, and is focusing its initial efforts on educating our state’s medical community. By collaborating with pharmacists and other allied health professionals, MAGF will raise awareness and enlist the support and participation of clinicians.
We will provide information for physicians, pharmacists, and others to help educate their patients and customers about the dangers of misuse and abuse of medications.
We will recognize and honor physicians and pharmacists who are changing their practice by using preventive materials; and support the implementation of the prescription drug monitoring program (PDMP) through ongoing communication with policy makers and media outlets.
